Related Experiment Video
Updated: Mar 19, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update
Diogo Costa Leandro de Oliveira1, Fernanda Boldrini Assunção1, Alair Agusto Sarmet Moreira Damas Dos Santos1
1Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil.
Insights
Hypertrophic cardiomyopathy (HCM) diagnosis and prognosis are enhanced by cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT). These imaging techniques aid in identifying subclinical cases and guiding patient management for this common genetic heart disease.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic cardiovascular disease.
- HCM is a leading cause of sudden cardiac death in young individuals.
- Early diagnosis and risk stratification are crucial for managing HCM.
Purpose of the Study:
- To elucidate the diagnostic and prognostic roles of Cardiac Magnetic Resonance (CMR) and Cardiac Computed Tomography (CCT) in HCM.
- To explore the application of CMR and CCT in screening for subclinical HCM phenotypes.
- To describe how advanced imaging influences the management strategies for HCM patients.
Main Methods:
- Review of current literature on CMR and CCT in HCM.
- Analysis of diagnostic accuracy and prognostic value of imaging findings.
- Discussion of imaging-guided therapeutic interventions.
Main Results:
- CMR and CCT demonstrate high sensitivity and specificity for HCM diagnosis.
- Imaging can identify subclinical disease and stratify risk.
- Advanced image analysis facilitates personalized management approaches.
Conclusions:
- CMR and CCT are indispensable tools for the comprehensive evaluation of HCM.
- These noninvasive imaging modalities are key to improving patient outcomes.
- Integrating imaging insights into clinical practice is vital for effective HCM management.
Abstract:
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease and represents the main cause of sudden death in young patients. Cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT) are noninvasive imaging methods with high sensitivity and specificity, useful for the establishment of diagnosis and prognosis of HCM, and for the screening of patients with subclinical phenotypes. The improvement of image analysis by CMR and CCT offers the potential to promote interventions aiming at stopping the natural course of the disease. This study aims to describe the role of RCM and CCT in the diagnosis and prognosis of HCM, and how these methods can be used in the management of these patients.
More Related Videos
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System IV: CMRI
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests